Severe Hypertriglyceridemia: From Pancreatitis Prevention to Cardiovascular Risk Reduction With Drs. James Underberg and Robert Rosenson
This activity is supported by independent educational grants from Arrowhead Pharmaceuticals, Inc.; Chiesi USA, Inc.; Cleerly Health; Esperion Therapeutics, Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc.

Already listened on another platform?
Overview
Provider Statement
This continuing education activity is provided by

Support Statement
This activity is supported by independent educational grants from Arrowhead Pharmaceuticals, Inc.; Chiesi USA, Inc.; Cleerly Health; Esperion Therapeutics, Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc.
Activity Description
In this episode, Drs Underberg and Rosenson review the latest clinical data on emerging therapies for the management of patients with severe hypertriglyceridemia.
Target Audience
The intended audience for this activity is physicians specializing in cardiology, lipidology, or primary care and allied health professionals involved in the management of patients with dyslipidemia.
Learning Objectives
Upon successful completion of this activity, participants should be better able to review the latest clinical data on emerging therapies for the management of patients with sHTG.
Activity Chair
James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLAClinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President, National Lipid Association
Past-President, American Board of Clinical Lipidology
Diplomate, American Board of Clinical Lipidology
New York, NY
Faculty
Robert S. Rosenson, MD, FACC, FAHA, FESC, FNLA, FACCPDr. Rony Shimony Distinguished Professor of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai
System Director, Metabolism and Lipids
Director, Cardiometabolic Research and Clinical Trials
Director, Advanced Fellowship in Preventive Cardiology
Mount Sinai Health System
Director, Cardiometabolic Disorders
Mount Sinai Fuster Heart Hospital
New York, NY
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This enduring material is approved for 1 year from the date of original release, November 15, 2026, to November 14, 2027.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objective, answer the polling and pretest questions, listen to the podcast, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible companies. All relevant financial relationships with ineligible companies have been mitigated prior to the commencement of the activity.
Activity Chair and Faculty report the following relevant financial relationship(s)
James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLA
Consultant: Amgen
Speaker Contracted by Ineligible Company: Amgen, Esperion Regeneron
Independent Research Contractor: Chiesi
Individual Stocks (publicly traded): Arrowhead, NewAmsterdam
Consultant: Amgen, Arrowhead, General Medicine, GSK, Lilly, Lipigon, Novartis, Novo Nordisk, Regeneron, Rona Therapeutic
Independent Research Contractor: 89Bio, Amgen, Arrowhead, AstraZeneca, Lilly, Merck, Novartis, Regeneron, Shanghai Argo, Verve Therapeutics
Stock Options: MediMergent
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Accessibility
Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners. Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at CME@VindicoCME.com. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com